CDTX - Cidara Therapeutics Inc
IEX Last Trade
11.9
-1.050 -8.824%
Share volume: 40,634
Last Updated: Fri 30 Aug 2024 08:59:04 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$12.95
-1.05
-8.11%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-03 | 2023-03-23 | 2023-05-11 | 2023-08-03 | 2023-11-02 | 2024-04-22 | 2024-05-15 | |
| Total revenue | 6.216 M | 40.744 M | 10.219 M | 25.990 M | 7.614 M | 12.718 M | 17.583 M | 8.463 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 387.000 K | 1.136 M | 1.563 M | |
| Gross profit | 6.216 M | 40.744 M | 10.219 M | 25.990 M | 7.614 M | 12.331 M | 16.447 M | 6.900 M | |
| 555.47% | -74.92% | 154.33% | -70.70% | 61.95% | 33.38% | -58.05% | |||
| Operating expenses | 19.329 M | 25.821 M | 23.486 M | 23.013 M | 20.445 M | 20.886 M | 22.521 M | 17.591 M | |
| Selling general and admin | 4.074 M | 5.780 M | 3.428 M | 4.298 M | 3.310 M | 3.556 M | 7.169 M | 5.998 M | |
| Research and development | 15.255 M | 20.041 M | 20.058 M | 18.715 M | 17.135 M | 17.330 M | 15.352 M | 11.593 M | |
| Total expenses | 19.329 M | 25.821 M | 23.486 M | 23.013 M | 20.445 M | 21.273 M | 23.657 M | 19.154 M | |
| 33.59% | -9.04% | -2.01% | -11.16% | 4.05% | 11.21% | -19.03% | |||
| Operating income | -13.113 M | 14.923 M | -13.267 M | 2.977 M | -12.831 M | -8.555 M | -6.074 M | -10.691 M | |
| Ebit | -13.113 M | 14.923 M | -13.267 M | 2.977 M | -12.831 M | -8.555 M | -6.074 M | -10.691 M | |
| Pretax income | -13.119 M | 14.978 M | -13.105 M | 3.209 M | -12.208 M | -7.942 M | -5.547 M | -10.326 M | |
| -214.17% | -187.49% | -124.49% | -480.43% | -34.94% | -30.16% | 86.15% | |||
| Income tax | 0.000 | 3.081 M | -2.809 M | 0.000 | 149.000 K | 230.000 K | 64.000 K | 0.000 | |
| Net income basic | -13.119 M | 11.897 M | -10.296 M | 2.532 M | -12.357 M | -8.172 M | -4.934 M | -10.326 M | |
| 190.69% | -186.54% | 124.59% | -588.03% | 33.87% | 39.62% | -109.28% | |||
| Net income | -13.119 M | 11.897 M | -10.296 M | 2.532 M | -12.357 M | -8.172 M | -4.934 M | -10.326 M | |
| 190.69% | -186.54% | 124.59% | -588.03% | 33.87% | 39.62% | -109.28% |